WallStreetZenWallStreetZen

NYSE: GMED
Globus Medical Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for GMED

Based on 12 analysts offering 12 month price targets for Globus Medical Inc.
Min Forecast
$61.00+14.79%
Avg Forecast
$70.17+32.04%
Max Forecast
$78.00+46.78%

Should I buy or sell GMED stock?

Based on 12 analysts offering ratings for Globus Medical Inc.
Buy
Strong Buy
4 analysts 33.33%
Buy
2 analysts 16.67%
Hold
5 analysts 41.67%
Sell
1 analysts 8.33%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GMED stock forecasts and price targets.

GMED stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Canaccord Genuity
Top 13%
88
HoldMaintains$67.00+26.08%2023-02-22
Wells Fargo
Bottom 47%
47
HoldMaintains$61.00+14.79%2023-02-22
Bank of America
Top 2%
99
SellDowngrades$63.00+18.55%2023-02-13
Truist Securities
Top 6%
95
HoldDowngrades$70.00+31.73%2023-02-10
Loop Capital
Top 15%
86
HoldDowngrades$70.00+31.73%2023-02-10
Morgan Stanley
Bottom 12%
12
HoldMaintains$78.00+46.78%2023-01-06
Barclays
Bottom 8%
8
Strong BuyInitiates Coverage On$69.00+29.85%2022-10-18
Jefferies
Top 14%
87
Strong BuyInitiates Coverage On$75.00+41.14%2022-10-12
Piper Sandler
Bottom 4%
4
Strong BuyMaintains$75.00+41.14%2022-08-05
Anonymous
Morgan Stanley
HoldMaintains$68.00+27.96%2022-05-12

1 of 2

Forecast return on equity

Is GMED forecast to generate an efficient return?
Company
14.4%
Industry
24.2%
Market
52.51%
GMED's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GMED forecast to generate an efficient return on assets?
Company
12.8%
Industry
12.49%
GMED is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GMED earnings per share forecast

What is GMED's earnings per share in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$2.41+27.51%
Avg 2 year Forecast
$2.59+37.04%
Avg 3 year Forecast
$2.65+40.21%
GMED's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

GMED revenue forecast

What is GMED's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$1.1B+10.44%
Avg 2 year Forecast
$1.2B+19.52%
Avg 3 year Forecast
$1.3B+24.33%
GMED's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GMED earnings growth forecast

How is GMED forecast to perform vs Medical Devices companies and vs the US market?
Company
16.33%
Industry
57.81%
Market
26.86%
GMED's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
GMED's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
GMED's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

GMED revenue growth forecast

How is GMED forecast to perform vs Medical Devices companies and vs the US market?
Company
8.8%
Industry
8.4%
Market
9.33%
GMED's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GMED's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GMED vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
GMED$53.14$70.17+32.04%Buy
IART$54.95$59.80+8.83%Hold
INSP$248.35$301.60+21.44%Strong Buy
NARI$62.00$85.43+37.79%Strong Buy
CNMD$97.00$108.75+12.11%Strong Buy
View Top Medical Device Stocks

Globus Medical Stock Forecast FAQ

Is Globus Medical Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NYSE: GMED) stock is to Buy GMED stock.

Out of 12 analysts, 4 (33.33%) are recommending GMED as a Strong Buy, 2 (16.67%) are recommending GMED as a Buy, 5 (41.67%) are recommending GMED as a Hold, 1 (8.33%) are recommending GMED as a Sell, and 0 (0%) are recommending GMED as a Strong Sell.

If you're new to stock investing, here's how to buy Globus Medical stock.

What is GMED's earnings growth forecast for 2023-2025?

(NYSE: GMED) Globus Medical's forecast annual earnings growth rate of 16.33% is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 57.81%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 26.86%.

Globus Medical's earnings in 2023 is $190,169,000.On average, 7 Wall Street analysts forecast GMED's earnings for 2023 to be $241,728,984, with the lowest GMED earnings forecast at $232,701,761, and the highest GMED earnings forecast at $252,762,257. On average, 3 Wall Street analysts forecast GMED's earnings for 2024 to be $259,783,431, with the lowest GMED earnings forecast at $247,747,133, and the highest GMED earnings forecast at $276,834,853.

In 2025, GMED is forecast to generate $265,801,580 in earnings, with the lowest earnings forecast at $265,801,580 and the highest earnings forecast at $265,801,580.

What is GMED's revenue growth forecast for 2023-2025?

(NYSE: GMED) Globus Medical's forecast annual revenue growth rate of 8.8% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.4%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.33%.

Globus Medical's revenue in 2023 is $1,022,843,000.On average, 6 Wall Street analysts forecast GMED's revenue for 2023 to be $113,302,687,822, with the lowest GMED revenue forecast at $110,544,369,539, and the highest GMED revenue forecast at $114,845,239,708. On average, 3 Wall Street analysts forecast GMED's revenue for 2024 to be $122,621,189,702, with the lowest GMED revenue forecast at $118,760,145,922, and the highest GMED revenue forecast at $125,601,076,170.

In 2025, GMED is forecast to generate $127,559,682,755 in revenue, with the lowest revenue forecast at $127,559,682,755 and the highest revenue forecast at $127,559,682,755.

What is GMED's forecast return on assets (ROA) for 2023-2025?

(NYSE: GMED) forecast ROA is 12.8%, which is higher than the forecast US Medical Devices industry average of 12.49%.

What is GMED's Price Target?

According to 12 Wall Street analysts that have issued a 1 year GMED price target, the average GMED price target is $70.17, with the highest GMED stock price forecast at $78.00 and the lowest GMED stock price forecast at $61.00.

On average, Wall Street analysts predict that Globus Medical's share price could reach $70.17 by Feb 22, 2024. The average Globus Medical stock price prediction forecasts a potential upside of 32.04% from the current GMED share price of $53.14.

What is GMED's Earnings Per Share (EPS) forecast for 2023-2025?

(NYSE: GMED) Globus Medical's current Earnings Per Share (EPS) is $1.89. On average, analysts forecast that GMED's EPS will be $2.41 for 2023, with the lowest EPS forecast at $2.32, and the highest EPS forecast at $2.52. On average, analysts forecast that GMED's EPS will be $2.59 for 2024, with the lowest EPS forecast at $2.47, and the highest EPS forecast at $2.76. In 2025, GMED's EPS is forecast to hit $2.65 (min: $2.65, max: $2.65).

What is GMED's forecast return on equity (ROE) for 2023-2025?

(NYSE: GMED) forecast ROE is 14.4%, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.